JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Biochemical Reagent
Signaling pathways

Signaling pathways

BA9136 LM-41

Summary: LM-41 is a Flufenamicacid-derived inhibitor that strongly reduces the expression of CTGF, Cyr61, Axl and NF2.
BA9137 LF3

Summary: A β-catenin/TCF4 interaction antagonist with antitumor activity for Wnt pathway and cancer

≥16.87 mg/mL
BA9138 Tegatrabetan

Summary: Tegatrabetan (BC2059) is an antagonist.
BA9139 ZW4864

Summary: ZW4864 is an orally active and selective inhibitor of βcatenin/B-Celllymphoma9 protein-protein interactions.
BA9140 NRX-252262

Summary: NRX-252262 is a potent interaction enhancer with homologous SCF.
BA9141 NRX-103094

Summary: NRX-103094 is a potent interaction enhancer with homologous SCF.
BA9142 β-catenin-IN-2

Summary: β-catenin-IN-2 is a potent inhibitor of compound H1B1.
BA9143 NRX-252114

Summary: NRX-252114 is a potent interaction enhancer with homologous SCF.
BA9145 NRX-2663

Summary: NRX-2663 is an interaction enhancer with homologous SCF.
BA9146 NRX-103095

Summary: NRX-103095 is an interaction enhancer with homologous SCF.